Vitus Malerczyk
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 26
- Antibiotics Pharmacokinetics and Efficacy 23
- Pharmacogenetics and Drug Metabolism 9
- Drug-Induced Adverse Reactions 4
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- Aleksandra Korn (7 shared papers)M. Verho (11 shared papers)Karl‐Heinz Lehr (4 shared papers)Bernd Rosenkranz (5 shared papers)M. Badian (5 shared papers)Werner Waldhäusl (3 shared papers)Paul H. Heintzen (5 shared papers)Claudia Lange (1 shared paper)
- Journals
- Infection (5 papers)European Journal of Clinical Pharmacology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Chemotherapy (2 papers)
- Partner nations
- GermanyBelgiumSouth Africa
In The Last Decade
Vitus Malerczyk
44 papers receiving 525 citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 96
- Pharmacology 258
- Pharmacology 63
- Clinical Biochemistry 47
- Endocrinology, Diabetes and Metabolism 100
Countries citing papers authored by Vitus Malerczyk
This map shows the geographic impact of Vitus Malerczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vitus Malerczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vitus Malerczyk more than expected).
Fields of papers citing papers by Vitus Malerczyk
This network shows the impact of papers produced by Vitus Malerczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vitus Malerczyk. The network helps show where Vitus Malerczyk may publish in the future.
Co-authors
The 25 scholars most cited alongside Vitus Malerczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 77 | |
| 2 | 1994 | 43 | |
| 3 | 1994 | 37 | |
| 4 | 1975 | 33 | |
| 5 | 1971 | 33 | |
| 6 | 1972 | 33 | |
| 7 | 1986 | 26 | |
| 8 | 1973 | 22 | |
| 9 | 1991 | 22 | |
| 10 | 1996 | 22 | |
| 11 | 1987 | 22 | |
| 12 | 1987 | 20 | |
| 13 | 1987 | 20 | |
| 14 | 1978 | 18 | |
| 15 | 1983 | 18 | |
| 16 | 1985 | 18 | |
| 17 | Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. | 1987 | 14 |
| 18 | 1972 | 14 | |
| 19 | 1987 | 12 | |
| 20 | 1974 | 11 |
About Vitus Malerczyk
Vitus Malerczyk is a scholar working on Pharmacology, Molecular Medicine, Pharmacology, Pediatrics, Perinatology and Child Health and Clinical Biochemistry, having authored 45 papers that have together received 638 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (9 papers), Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (5 papers), Drug-Induced Adverse Reactions (4 papers), Diabetes Treatment and Management (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Molecular Medicine (96 citations), Pharmacology (258 citations), Pharmacology (63 citations), Clinical Biochemistry (47 citations) and Endocrinology, Diabetes and Metabolism (100 citations). Vitus Malerczyk has collaborated with scholars based in Germany, Belgium and South Africa. Frequent co-authors include Aleksandra Korn, M. Verho, Karl‐Heinz Lehr, Bernd Rosenkranz, M. Badian, Werner Waldhäusl, Paul H. Heintzen, Claudia Lange, Kelly Claire Simon and Norbert Hendrik Lameire. Their work appears in journals such as Infection, European Journal of Clinical Pharmacology, Journal of Antimicrobial Chemotherapy, Clinical Pharmacology & Therapeutics and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.